Trial intelligence / Profile preview

SPEEDA vs VERORAB for Post-Exposure Rabies Prophylaxis

NCT01137045Phase 4Completed

Sponsor
Queen Saovabha Memorial Institute
Start
Jun 2010
Primary completion
Apr 2018
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of SPEEDA + TRCS SPEEDA in rabies, sponsored by Queen Saovabha Memorial Institute. Started Jun 2010; status: completed.

02

Drugs

SPEEDA + TRCS SPEEDA
03

Conditions

rabies

Beyond the preview

Go deeper on NCT01137045.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01137045.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call